The Immuno-Oncology program is designed to help the busy clinician keep on top of the rapidly developing field of immunotherapy as it relates to oncology. The program address a wide variety of topics including cancer immunobiology, classes of agents, potential predictive biomarkers, clinical activity in the areas of melanoma and non-small cell lung cancer, response determination and the management of immune-related adverse events.
- Describe the components of the normal human immune system and their role in surveillance and anti-tumor activity
- Identify the mechanisms by which cancer vaccines may induce specific immunity to cancer
- Examine other potential biomarkers of benefit to immune checkpoint blockade
- Identify the immune modulating agents that have been used in the clinic
- Apply RECIST-based response assessments to patients receiving cancer immunotherapy in the clinic
- Describe management strategies for the toxicities associated with immunotherapies
ACGME Competencies addressed:
- Medical Knowledge
Institute of Medicine (IOM) Competencies:
- Working as a part of interprofessional teams
- Delivering patient-centered care
- Practicing evidence-based medicine
NOTE: This course is accessible through mobile devices as well as personal computers.
IMPORTANT NOTE: This activity was made available on December 16, 2015 and will be reviewed on an annual basis to determine continued availability. The Immuno-Oncology Program expires on December 16, 2018. Users must complete all necessary course components by this date to be eligible to claim MOC and CME/CE credit.
8 Credits/Points are available for participation in this course. Certificate and credit types available include:
- AMA PRA Category 1 Credits™
- ABIM MOC Points
- CNE Contact Hours
- CPE Credits
- Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
- Certificate of Completion may be used to document participation, but no credit will be conferred.